IMPLANTABLE DEFIBRILLATOR GEM DR MODEL 7271 - ANVISA register 10339190053 and DEFIBRILLATOR IMPLANTAVEL 7223Cx - ANVISA registration 10339190013 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 MEDTRONIC COMERCIAL LTDA 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    775
  • 날짜
    2004-06-16
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    MEDTRONIC recommends: If the last monitoring has been in the last three months and records are available, check the battery voltage recorded and the charge time of the capacitor as below. · For all other cases, schedule a follow-up consultation as soon as possible and check the charge time of the capacitor as follows. · Schedule the exchange for any device with the following specification: Battery voltage of 5.16 V or less (NEW RECOMMENDATION) OR Charging time of 18 seconds or more. · If the battery voltage is greater than 5.16 Volts, check the charging time: If it is less than 18 seconds and greater than 14 seconds, set the Auto Capacitor Format Interval to one month. No additional reprogramming is required if the charge time is less than 14 seconds, or if the capacitor format is already programmed for one month. Continue to follow these patients at least every three months. These recommendations relate only to Micro Jewel 11 and Gem DR DCls identified by the serial numbers as attached list. No other Micro Jewell Model 7223Cx or GEM DR Model 7271 has been affected. Globally there were thirty (30) Micro Jewel 11 devices with capacitors that obtained unexpected circuit load performance at near-ERI battery voltages. Six (6) of these occurred during cardiac arrhythmias, resulting in undesired therapy. Although all reports with field action with the dates of the Micro Jewel 11 involved, it is possible that some DR GEM devices with suspected capacitors may exhibit similar behavior. So this recommendation applies to both Micro Jewel 11 (-1386 units globally) and GEM DR (-435 globally active) with suspect capacitors. These devices were deployed in 1997 and 1998.
  • 원인
    Capacitors under suspicion of not being able to deliver near high voltage energy or eri (4.91 v) and continuing through eol (4.57 v).
  • 조치
    Medtronic is providing an update over previous notifications for GEM Dr Model 7271 and Micro Jewelll Model 7223 Cx Implantable Cardioversion Defibrillators (DCls). This update replaces the recommendations made for the Model 7271 GEM in December 1999 and the Micro Jewelll Model 7223Cx supplied in August 1999 and November 2000 on capacitors in the identified population.

Manufacturer

  • Source
    ANVSANVISA